Patents by Inventor Guillermo Ceballos

Guillermo Ceballos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220401409
    Abstract: The present invention relates to compounds and compositions and their applications as pharmaceuticals for treating, preventing, or reversing injury to skeletal or cardiac muscles, for treating or preventing diseases relating to the structure and function of skeletal or cardiac muscle, and for inducing regeneration or restructuring of skeletal or cardiac muscle as a means of treating diseases relating to abnormalities in skeletal or cardiac muscle structure and function in a human or animal subject. Further aspects relate to the same or similar applications for bone and bone diseases.
    Type: Application
    Filed: February 4, 2022
    Publication date: December 22, 2022
    Inventors: George Frederic SCHREINER, Guillermo CEBALLOS, Sundeep DUGAR
  • Patent number: 11273144
    Abstract: The present invention relates to compounds and compositions and their applications as pharmaceuticals for treating, preventing, or reversing injury to skeletal or cardiac muscles, for treating or preventing diseases relating to the structure and function of skeletal or cardiac muscle, and for inducing regeneration or restructuring of skeletal or cardiac muscle as a means of treating diseases relating to abnormalities in skeletal or cardiac muscle structure and function in a human or animal subject. Further aspects relate to the same or similar applications for bone and bone diseases.
    Type: Grant
    Filed: January 14, 2020
    Date of Patent: March 15, 2022
    Assignee: EPIRIUM BIO INC.
    Inventors: George Frederic Schreiner, Guillermo Ceballos, Sundeep Dugar
  • Publication number: 20200390741
    Abstract: The present invention relates to compounds and compositions and their applications as pharmaceuticals for treating, preventing, or reversing injury to skeletal or cardiac muscles, for treating or preventing diseases relating to the structure and function of skeletal or cardiac muscle, arid for inducing regeneration or restructuring of skeletal or cardiac muscle as a means of treating diseases relating to abnormalities in skeletal or cardiac muscle structure and function in a human or animal subject. Further aspects relate to the same or similar applications for bone and bone diseases.
    Type: Application
    Filed: January 14, 2020
    Publication date: December 17, 2020
    Inventors: George Frederic SCHREINER, Guillermo CEBALLOS, Sundeep DUGAR
  • Publication number: 20190357560
    Abstract: Cacao pod pericarp (CP) is used to produce a food ingredient, or flour, using convective-heat or freeze-drying and/or microwave drying methods. The observed physical and technological properties of dried CP revealed its potential application as an ingredient in manufactured food products. The levels of bioactive compounds are significantly increased in the dried CP samples compared to the raw material, especially in the case of the freeze dried methods. The commercially advantageous use of the cacao pod waste material can be used in treatments for humans and animals in order to improve several anthropometric measurements or cardiometabolic markers in the blood and to improve the composition and mass of the body. Embodiments for treating humans and animals include administering orally to decrease LDL/HDL ratios or triglyceride/HDL ratios, or administering topically as a cosmetic to treat fine lines, wrinkles, skin discoloration, and other skin conditions.
    Type: Application
    Filed: August 12, 2019
    Publication date: November 28, 2019
    Inventor: Guillermo Ceballos
  • Publication number: 20180193306
    Abstract: The present invention relates to compounds and compositions and their applications as pharmaceuticals for treating, preventing, or reversing injury to skeletal or cardiac muscles, for treating or preventing diseases relating to the structure and function of skeletal or cardiac muscle, and for inducing regeneration or restructuring of skeletal or cardiac muscle as a means of treating diseases relating to abnormalities in skeletal or cardiac muscle structure and function in a human or animal subject. Further aspects relate to the same or similar applications for bone and bone diseases.
    Type: Application
    Filed: February 20, 2018
    Publication date: July 12, 2018
    Applicant: Cardero Therapeutics, Inc.
    Inventors: George F. SCHREINER, Guillermo CEBALLOS, Sundeep DUGAR
  • Patent number: 9901564
    Abstract: The present invention relates to compounds and compositions and their application as pharmaceuticals for treating, preventing, or reversing injury to skeletal or cardiac muscles, for treating or preventing diseases relating to the structure and function of skeletal or cardiac muscle, and for inducing regeneration or restructuring of skeletal or cardiac muscle as a means of treating diseases relating to abnormalities in skeletal or cardiac muscle structure and function in a human or animal subject.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: February 27, 2018
    Assignee: CARDERO THERAPEUTICS, INC.
    Inventors: George F. Schreiner, Guillermo Ceballos, Sundeep Dugar
  • Publication number: 20150080328
    Abstract: The present invention relates to compounds and compositions and their application as pharmaceuticals for treating, preventing, or reversing injury to skeletal or cardiac muscles, for treating or preventing diseases relating to the structure and function of skeletal or cardiac muscle, and for inducing regeneration or restructuring of skeletal or cardiac muscle as a means of treating diseases relating to abnormalities in skeletal or cardiac muscle structure and function in a human or animal subject.
    Type: Application
    Filed: March 22, 2013
    Publication date: March 19, 2015
    Inventors: Francisco Villarreal, George F. Schreiner, Guillermo Ceballos
  • Publication number: 20120095063
    Abstract: The present invention relates to compositions and methods for prophylactic and/or therapeutic treatment of conditions related to mitochondrial function. In various aspects, the present invention comprises administering one or more compounds selected from the group consisting of epicatechin, an epicatechin derivative, catechin, a catechin derivative, nicorandil, and a nicorandil derivative in an amount effective to stimulate mitochondrial function in cells. The methods and compositions described herein provide for reducing infarct size in the heart following permanent ischemia or ischemia/reperfusion (IR) event or method for delaying, attenuating or preventing adverse cardiac remodeling, and can assist in prevention of impaired mitochondria biogenesis and thus prevention of the consequences of impaired mitochondrial biogenesis in various diseases and conditions, as well as provide for the active therapy of mitochondrial depletion that may have already occurred.
    Type: Application
    Filed: April 17, 2010
    Publication date: April 19, 2012
    Inventors: Francisco Villareal, Pam R. Taub, Alan S. Maisel, George F. Schreiner, Anne Murphy, Katrina Yamazaki, Guillermo Ceballos
  • Patent number: 3974968
    Abstract: This invention refers to a process for the manufacture of sorghum flour and the object of this invention is to obtain flour by a dry process, avoiding with it production of sorghum flour by a humid method.
    Type: Grant
    Filed: December 26, 1974
    Date of Patent: August 17, 1976
    Inventor: Ing. Guillermo Ceballos-Aquilera